Back to FDA Applications sponsored by MALLINCKRODT INC

FDA Drug Application 021217 by MALLINCKRODT INC

Application Number021217
Application Type New Drug Application
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Priority
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP03/1/2010N25605000 5/23/2010
AP03/1/2010N25606000 5/23/2010
AP03/1/2010N33132000REMS 7/11/2012
AP03/1/2010N24882000 3/2/2010
AP03/1/2010N24883000 3/2/2010
AP03/1/2010N24917000 3/3/2010
AP03/24/2010S25146001 3/31/2010
AP07/9/2012SLR33143002 7/11/2012
AP07/9/2012SLR33165002 7/12/2012
AP08/24/2012SLR33562004 8/28/2012
AP08/24/2012SLR33574004 8/28/2012
AP08/24/2012SLR33578004 8/28/2012
AP03/18/2013SLR35476005 3/18/2013
AP03/18/2013SLR35477005 3/19/2013
AP04/15/2013SLR35736006 4/17/2013
AP06/2/2015SLR42979009 6/4/2015
AP06/2/2015SLR42986009 6/4/2015
AP06/17/2014SLR39584012 6/19/2014
AP06/17/2014SLR39665012 6/26/2014
AP04/16/2014SLR39065013 4/16/2014
AP04/16/2014SLR39076013 4/17/2014
AP08/19/2014S40271014 8/20/2014
AP06/26/2015S43226015 7/2/2015
AP04/20/2016S45718017 4/22/2016
AP09/30/2016S47267020 10/4/2016

Back to FDA Applications sponsored by MALLINCKRODT INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.